Responding to NHS England’s Cancer Waiting Times for July 2018, Gunes Kalkan, Head of Evidence, Policy and Campaigns at Breast Cancer Care,...

13 September 2018

Responding to an announcement from Jeane Freeman MSP, Health Secretary, revealing that 1,761 women aged over 71 in Scotland were not invited for...

13 September 2018

Responding to a new online tool that could better predict the long-term risk of oestrogen receptor positive breast cancer returning and the need for...

24 August 2018

Responding to the updated draft guidance from NICE to not recommend Perjeta (pertuzumab) for routine NHS use after surgery for early HER2-positive...

17 August 2018

Responding to news that health officials are investigating concerns that adults who should have been invited for breast and bowel cancer screening...

11 August 2018

Perjeta, given in combination with Herceptin (trastuzumab) and docetaxel (a chemotherapy drug), is a first-line treatment for patients with HER2-...

10 August 2018

Discussing the news that NHS trusts are being encouraged to move away from the breast cancer drug Herceptin to use a biologically similar medicine,...

31 July 2018

We have responded to National Cancer Patient Experience Survey showing satisfaction with NHS cancer care is at a record high. ...

27 July 2018

The Secretary of State for Health and Social Care, Matt Hancock today outlined his commitments to workforce, technology and prevention, in his first...

20 July 2018